Login

Consolidated balance sheets

In millions of USD, except per-share amounts
Q4 FY2023
As of Dec 31, 2023
ASSETS
CURRENT ASSETS:
Cash and cash equivalents
Accounts receivable, net of credit losses of zero as of December 31, 2023 and 2022, respectively
Other current assets
Inventory
TOTAL CURRENT ASSETS
NON-CURRENT ASSETS:
Property and equipment, net
Restricted cash
Other assets
TOTAL NON-CURRENT ASSETS
TOTAL ASSETS
LIABILITIES AND REDEEMABLE CROSSOVER PREFERRED SHARES, NET OF CAPITAL DEFICIENCY
CURRENT LIABILITIES:
Accounts payable and accruals:
Trade
Other
SAFE liability
Convertible loans
Current maturities of bridge loans
TOTAL CURRENT LIABILITIES
NON-CURRENT LIABILITIES
Bridge loans
Redeemable crossover preferred shares - put option derivative
TOTAL LIABILITIES
Redeemable crossover preferred shares and incentive shares, par value NIS 0.01 per share; 2,800,000 and zero0 shares authorized as of December 31, 2023 and 2022; 1,850,147 and zero0 shares issued and outstanding at December 31, 2023 and 2022, respectively
SHAREHOLDERS’ CAPITAL DEFICIENCY:
Ordinary shares, par value NIS 0.01 per share; 40,000,000 shares authorized as of December 31, 2023 and 2022; 15,505,853 shares and 15,477,374 shares issued and outstanding at December 31, 2023 and 2022, respectively
Additional paid-in capital
Accumulated deficit
Total redeemable crossover preferred shares and capital deficiency
Total liabilities, net of capital deficiency

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support